Increasing Prevalence of Methicillin-Resistant Staphylococcus aureus Causing Nosocomial Infections at a University Hospital in Taiwan from 1986 to 2001

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 4, 2004, Pages 1361-1364

  Hsueh, Po Ren ^a   Teng, Lee Jene ^b   Chen, Wen Hwei ^a   Pan, Huei Ju ^a   Chen, Mei Lin ^a   Chang, Shan Chwen ^a   Luh, Kwen Tay ^a   Lin, Fang Yue ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERTAPENEM; FUSIDIC ACID; GARENOXACIN; GATIFLOXACIN; GLYCOPEPTIDE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METICILLIN; MOXIFLOXACIN; OXACILLIN; PENICILLIN G; SITAFLOXACIN; TEICOPLANIN; TELITHROMYCIN; VANCOMYCIN;

ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; HOSPITAL INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TAIWAN; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HOSPITALS, UNIVERSITY; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TAIWAN;

EID: 1642502296     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.4.1361-1364.2004     Document Type: Article

References (25)

1. Anonymous. 2002. Staphylococcus aureus resistant to vancomycin-United States. Morb. Mortal. Wkly. Rep. 51:565-567.
2. Anonymous. 1999. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999. Am. J. Infect. Control 27:520-532.
3. Bell, J. M., J. D. Turnidge, and SENTRY APAC Participants. 2002. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY Antimicrobial Surveillance Program, 1998-1999. Antimicrob. Agents Chemother. 46:879-881.
4. Canton, R., E. Loza, M. I. Morosini, and F. Baquero. 2001. Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000. J. Antimicrob. Chemother. 50(Suppl. S1):9-24.
5. Chambers, H. F. 2001. The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 7:178-182.
6. Elsaghier, A. A., H. M. Aucken, J. M. Hamilton-Miller, S. Shaw, and C. C. Kibbler. 2002. Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection. J. Antimicrob. Chemother. 49:423-424.
7. Evans, M. E. 2002. Selection of oxacillin resistance in oxacillin-sensitive Staphylococcus aureus through exposure to ciprofloxacin but not piperacillin/ tazobactam. Eur. J. Clin. Microbiol. Infect. Dis. 21:621-623.
8. Fridkin, S. K., C. D. Steward, and J. R. Edwards. 1999. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Clin. Infect. Dis. 29:245-252.
9. Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes. 1988. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16:128-140.
10. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
11. Ho, M., L. C. McDonald, T. L. Lauderdale, L. L. Yeh, P. C. Chen, and Y. R. Shiau. 1999. Surveillance of antibiotic resistance in Taiwan, 1998. J. Microbiol. Immunol. Infect. 32:239-249.
12. Hsueh, P. R., C. Y. Liu, and K. T. Luh. 2002. Current status of antimicrobial resistance in Taiwan. Emerg. Infect. Dis. 8:132-137.
13. Hsueh, P. R., M. L. Chen, C. C. Sun, W. H. Chen, H. J. Pan, L. S. Yang, S. C. Chang, S. W. Ho, C. Y. Lee, W. C. Hsieh, and K. T. Luh. 2002. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg. Infect. Dis. 8:63-68.
14. Huang, A. H., J. J. Yan, and J. J. Wu. 2000. Rapid dissemination of Staphylococcus aureus with classic oxacillin resistance phenotype at a new university hospital. J. Hosp. Infect. 44:309-315.
15. Kunin, C. M. 1993. Resistance to antimicrobial drugs: a worldwide calamity. Ann. Intern. Med. 118:557-561.
16. Low, D. E., M. Muller, C. L. Duncan, B. M. Willey, J. C. de Azavedo, A. McGeer, B. N. Kreiswirth, S. Pong-Poster, and D. J. Bast. 2002. Activity of BMY-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance. Antimicrob. Agents Chemother. 46:1119-1121.
17. Malathum, K., T. M. Coque, K. V. Singh, and B. E. Murray. 1999. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria. Antimicrob. Agents Chemother. 43:930-936.
18. McDonald, L. C., H. T. Yu, H. C. Yin, A. C. Hsiung, M. Ho, and Antibiotic Use Working Group. 2001. Use and abuse of surgical antibiotic prophylaxis in hospitals in Taiwan. J. Formos. Med. Assoc. 100:5-13.
19. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standards. Fifth edition. M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
20. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing: thirteenth informational supplement. M100-S13 (M7). National Committee for Clinical Laboratory Standards, Wayne, Pa.
21. Presterl, E., P. Mueller-Uri, A. Grisold, A. Georgopoulos, and W. Graninger. 2001. Ciprofloxacin- and methicillin-resistant Staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid. Eur. J. Clin. Microbiol. Infect. Dis. 20:486-489.
22. Salmenlinna, S., O. Lyytikainen, and J. Vuopio-Varkila. 2002. Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg. Infect. Dis. 8:602-607.
23. Schmitz, F. J., A. C. Fluit, S. Brisse, J. Verhoef, K. Kohrer, and D. Milatovic. 1999. Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates. FEMS Immunol. Med. Microbiol. 26:281-287.
24. Tenover, F. C., J. W. Biddle, and M. V. Lancaster. 2001. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg. Infect. Dis. 7:327-332.
25. Weinstein, R. A. 2001. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg. Infect. Dis. 7:188-192.